Skip to contentR
Reflect Scientific, Inc.
R
RSCFReflect Scientific, Inc. Q3 2024 · 10-Q
Revenue$514.02K$514.02K−2.3% vs Q3 2023 Net Income$109.93K$109.93K+27.4% vs Q3 2023 EPS Diluted$0.00$0.00— vs Q3 2023 Gross Profit$327,826−0.7% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Reflect Scientific, Inc. · CIK 1103090 · Engraved from SEC EDGAR
Operating Cash Flowderived-$72,288N/M Margins · derivedGross margin63.8%+1.0 pt vs Q3 2023
Operating margin19.3%+3.9 pt vs Q3 2023
Net margin21.4%+5.0 pt vs Q3 2023
ended Sep 30, 2024 · filed Nov 12, 2024 · 43 d after period end